Not exactly .. safety was established in HIV trial
Post# of 145879
My question is: what reference spike protein REGN's used; if it's from six months ago, what are the odds the strain Trump and associates have has mutated, and what would REGN's PAB's binding affinity be as a result?
Reinfections may be a function of adaptive immunity decreasing over time, but genetic sequencing has shown mutations from first and second infections. Viral protein-targeting P/MABs largely have the same issue as classic vaccines in that regard.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)